Vaccine Development Global Program

Developing new, affordable vaccines for the people who need them most

Vaccines are one of the most effective, affordable, and beneficial tools in public health. Because market forces alone are not always strong enough to drive the development of vaccines most urgently needed in lower-income countries, PATH’s Vaccine Development Global Program is stepping in to fill the gap. Find out more »

India rolls out ROTAVAC® in the private sector

India introduces ROTAVAC in private sector.On March 9,  India rolled out an indigenously developed and manufactured rotavirus vaccine, ROTAVAC®, for the private market. PATH, a key partner in the development of ROTAVAC® since 2001, worked with the Indian Department of Biotechnology, the Society for Applied Studies, and Bharat Biotech on the clinical trials that demonstrated the safety and efficacy of the vaccine. Read the e-newsletter article »

Photo credit: Office of the Prime Minister of India


on our site: See what’s new from our pneumococcal vaccine project »

on our site: Our new RSV vaccine landscape is out! See the snapshot (35.01 KB PDF) »

in the news: PATH and Affinivax collaborate to advance innovative technology for pneumococcal vaccines »

update: New collaboration to support influenza vaccine development in China (PDF 65.12 KB) »



Sign up for our e-newsletter

Our e-newsletter, Vaccines for the Future, provides quarterly updates on our efforts to develop innovative, safe, effective, and affordable vaccines. It includes updates on our progress, partnerships, and specific activities. Sign up now »

Visit the Vaccine Resource Library

PATH’s Vaccine Resource Library (VRL) seeks to gather the world’s best immunization resources in a single, easy-to-use website. The VRL offers high-quality, scientifically accurate documents and links on specific diseases and topics in immunization. Learn more »

Banner photos, clockwise from left: PATH/Gabe Bienczycki; PATH/Chutima Suraratdecha; PATH.

Comments are closed.